Tequin, manufactured by Bristol-Myers Squibb, is an oral or intravenous antibiotic prescribed for the treatment of chronic bronchitis, sinusitis, pneumonia and urinary tract infections. A study published in the March, 2006 issue of the New England Journal of Medicine illustrated that Tequin causes fluctuating blood sugar levels in some patients, which can lead to diabetes.

Tequin's risk of causing diabetes has led to it being classified as a defective drug. Often drug companies are negligent and do not fully inform doctors and patients about these dangerous side effects. Bristol-Myers Squibb may be required to compensate individuals who have developed diabetes due to Tequin. If you have become diabetic due to taking Tequin, you should contact Aylstock, Witkin, Kreis & Overholtz at (888) 255-2956 to learn more about your legal rights and the possibility of compensation.

Side Effects of Tequin

A study conducted by a public interest group documented more than 388 Tequin patients who developed some type of blood sugar irregularity. Of the 388, approximately 20 patients died due to Tequin's diabetes related side effects. Bristol-Myers Squibb voluntarily halted production of Tequin but is not willing to recall any remaining Tequin currently on the market.

Bristol-Myers Squibb's opposition to remove Tequin from the market or fully inform doctors and patients about its serious side effects magnifies the company's negligence. By law, pharmaceutical companies are required to fully inform doctors and patients about the harmful side effects of their drugs. Bristol-Myers Squibb's disregard for their consumers' well-being has made them potentially liable for causing diabetes in patients using Tequin. Contact the defective drug attorneys of Aylstock, Witkin, Kreis & Overholtz today at (877) 810-4808 to learn more about your rights if you have developed diabetes due to taking Tequin.